618 related articles for article (PubMed ID: 19828373)
1. Quality of life after successful treatment of early-stage Hodgkin's lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial.
Heutte N; Flechtner HH; Mounier N; Mellink WA; Meerwaldt JH; Eghbali H; van't Veer MB; Noordijk EM; Kluin-Nelemans JC; Lampka E; Thomas J; Lugtenburg PJ; Viterbo L; Carde P; Hagenbeek A; van der Maazen RW; Smit WG; Brice P; van Marwijk Kooy M; Baars JW; Poortmans P; Tirelli U; Leeksma OC; Tomsic R; Feugier P; Salles G; Gabarre J; Kersten MJ; Van Den Neste E; Creemers GJ; Gaillard I; Meijnders P; Tertian G; Reman O; Muller HP; Troncy J; Blanc M; Schroyens W; Voogt PJ; Wijermans P; Rieux C; Fermé C; Henry-Amar M;
Lancet Oncol; 2009 Dec; 10(12):1160-70. PubMed ID: 19828373
[TBL] [Abstract][Full Text] [Related]
2. Quality of life assessment in Hodgkin's disease: a new comprehensive approach. First experiences from the EORTC/GELA and GHSG trials. EORTC Lymphoma Cooperative Group. Groupe D'Etude des Lymphomes de L'Adulte and German Hodgkin Study Group.
Flechtner H; Rüffer JU; Henry-Amar M; Mellink WA; Sieber M; Fermé C; Eghbali H; Josting A; Diehl V
Ann Oncol; 1998; 9 Suppl 5():S147-54. PubMed ID: 9926255
[TBL] [Abstract][Full Text] [Related]
3. Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group.
Kreissl S; Mueller H; Goergen H; Mayer A; Brillant C; Behringer K; Halbsguth TV; Hitz F; Soekler M; Shonukan O; Rueffer JU; Flechtner HH; Fuchs M; Diehl V; Engert A; Borchmann P;
Lancet Oncol; 2016 Oct; 17(10):1453-1462. PubMed ID: 27612583
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in patients with glioblastoma: a randomised controlled trial.
Taphoorn MJ; Stupp R; Coens C; Osoba D; Kortmann R; van den Bent MJ; Mason W; Mirimanoff RO; Baumert BG; Eisenhauer E; Forsyth P; Bottomley A; ; ;
Lancet Oncol; 2005 Dec; 6(12):937-44. PubMed ID: 16321761
[TBL] [Abstract][Full Text] [Related]
6. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
Li Q; Lin Y; Qiu Y; Gao B; Xu Y
Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
[TBL] [Abstract][Full Text] [Related]
7. Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adulte.
van der Kaaij MA; Heutte N; Le Stang N; Raemaekers JM; Simons AH; Carde P; Noordijk EM; Fermé C; Thomas J; Eghbali H; Kluin-Nelemans HC; Henry-Amar M; ;
J Clin Oncol; 2007 Jul; 25(19):2825-32. PubMed ID: 17515571
[TBL] [Abstract][Full Text] [Related]
8. Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.
Grande GE; Farquhar MC; Barclay SI; Todd CJ
Palliat Support Care; 2009 Sep; 7(3):289-97. PubMed ID: 19788770
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data.
Bordeleau L; Szalai JP; Ennis M; Leszcz M; Speca M; Sela R; Doll R; Chochinov HM; Navarro M; Arnold A; Pritchard KI; Bezjak A; Llewellyn-Thomas HA; Sawka CA; Goodwin PJ
J Clin Oncol; 2003 May; 21(10):1944-51. PubMed ID: 12743147
[TBL] [Abstract][Full Text] [Related]
10. Premature ovarian failure and fertility in long-term survivors of Hodgkin's lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study.
van der Kaaij MA; Heutte N; Meijnders P; Abeilard-Lemoisson E; Spina M; Moser EC; Allgeier A; Meulemans B; Simons AH; Lugtenburg PJ; Aleman BM; Noordijk EM; Fermé C; Thomas J; Stamatoullas A; Fruchart C; Brice P; Gaillard I; Bologna S; Ong F; Eghbali H; Doorduijn JK; Morschhauser F; Sebban C; Roesink JM; Bouteloup M; Van Hoof A; Raemaekers JM; Henry-Amar M; Kluin-Nelemans HC
J Clin Oncol; 2012 Jan; 30(3):291-9. PubMed ID: 22184372
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial.
Delforge M; Dhawan R; Robinson D; Meunier J; Regnault A; Esseltine DL; Cakana A; van de Velde H; Richardson PG; San Miguel JF
Eur J Haematol; 2012 Jul; 89(1):16-27. PubMed ID: 22469559
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy.
Meyer F; Fortin A; Gélinas M; Nabid A; Brochet F; Têtu B; Bairati I
J Clin Oncol; 2009 Jun; 27(18):2970-6. PubMed ID: 19451440
[TBL] [Abstract][Full Text] [Related]
13. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
Park KU
Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in advanced non-small cell lung cancer: correlates and comparisons to normative data.
Larsson M; Ljung L; Johansson BB
Eur J Cancer Care (Engl); 2012 Sep; 21(5):642-9. PubMed ID: 22519874
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072).
Coens C; van der Graaf WT; Blay JY; Chawla SP; Judson I; Sanfilippo R; Manson SC; Hodge RA; Marreaud S; Prins JB; Lugowska I; Litière S; Bottomley A
Cancer; 2015 Sep; 121(17):2933-41. PubMed ID: 26033286
[TBL] [Abstract][Full Text] [Related]
16. Role functioning before start of adjuvant treatment was an independent prognostic factor for survival and time to failure. A report from the Nordic adjuvant interferon trial for patients with high-risk melanoma.
Brandberg Y; Johansson H; Aamdal S; Bastholt L; Hernberg M; Stierner U; von der Maase H; Hansson J;
Acta Oncol; 2013 Aug; 52(6):1086-93. PubMed ID: 23621752
[TBL] [Abstract][Full Text] [Related]
17. Quality of life after palliative treatment for oesophageal carcinoma -- a prospective comparison between stent placement and single dose brachytherapy.
Homs MY; Essink-Bot ML; Borsboom GJ; Steyerberg EW; Siersema PD;
Eur J Cancer; 2004 Aug; 40(12):1862-71. PubMed ID: 15288288
[TBL] [Abstract][Full Text] [Related]
18. Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational study.
Lebret T; Culine S; Davin JL; Hennequin C; Mignard JP; Moreau JL; Rossi D; Zerbib M; Mahmoudi A; Latorzeff I
Aging Male; 2014 Jun; 17(2):87-93. PubMed ID: 24576298
[TBL] [Abstract][Full Text] [Related]
19. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
Quinten C; Coens C; Mauer M; Comte S; Sprangers MA; Cleeland C; Osoba D; Bjordal K; Bottomley A;
Lancet Oncol; 2009 Sep; 10(9):865-71. PubMed ID: 19695956
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin's disease: quality of life in future trials.
Kaasa S; Knobel H; Loge JH; Hjermstad MJ
Ann Oncol; 1998; 9 Suppl 5():137-45. PubMed ID: 9926254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
